Bellecapital’s Idexx Laboratories IDXX Stock Holding History

Bellecapital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,400	Closed	-$252K	–	51
2014 Q4	$252K	Hold	3,400	–	–	0.34%	45
2014 Q3	$200K	Buy	+3,400	New	+$215K	0.23%	51

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellecapital's IDXX Position: Q1 2015 in Review

Bellecapital sold out of Idexx Laboratories (IDXX) in Q1 2015, closing a stake of 3,400 shares — an estimated $252K sold.

Bellecapital first reported a position in IDXX in Q3 2014 and held it in 2 quarters. The position peaked at $252K in Q4 2014. 344 funds tracked by Wall St. Rank hold IDXX as of Q1 2015.

Bellecapital reported no remaining Idexx Laboratories position as of Q1 2015 after selling out during the quarter.
Bellecapital sold 3,400 Idexx Laboratories shares in Q1 2015, an estimated $252K.
Bellecapital first reported a position in Idexx Laboratories in Q3 2014 and held it in 2 quarters.
Bellecapital's Idexx Laboratories position peaked at $252K in Q4 2014.
344 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2015.

Based on Bellecapital's 13F filing for Q1 2015, filed 27 Apr 2015.